Jennifer L Kelly

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Vitamin D and non-Hodgkin lymphoma risk in adults: a review
    Jennifer L Kelly
    Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14642, USA
    Cancer Invest 27:942-51. 2009
  2. ncbi A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults
    Jennifer L Kelly
    Department of Community and Preventive Medicine, University of Rochester, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA
    Cancer Causes Control 21:1265-75. 2010
  3. ncbi High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
    Makiko Ban-Hoefen
    James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    Leuk Lymphoma 53:830-5. 2012
  4. ncbi The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
    Jennifer L Kelly
    School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA
    Ann Epidemiol 22:855-62. 2012
  5. ncbi Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
    Jennifer L Kelly
    School of Medicine and Dentistry, University of Rochester, NY, USA
    Cancer Causes Control 23:1017-29. 2012
  6. ncbi Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
    Jonathan W Friedberg
    James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    Br J Haematol 146:282-91. 2009
  7. ncbi Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
    Matthew T Drake
    College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 28:4191-8. 2010
  8. ncbi Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era
    Sarah F Keller
    James P Wilmot Cancer Center, University of Rochester, Rochester, New York 14642, USA
    Biol Blood Marrow Transplant 18:640-7. 2012
  9. ncbi Testicular cancer survivorship: research strategies and recommendations
    Lois B Travis
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA
    J Natl Cancer Inst 102:1114-30. 2010
  10. ncbi The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma
    Jonathan W Friedberg
    James P Wilmot Cancer Center, University of Rochester, Rochester, NYm, USA
    Blood 117:2807-12. 2011

Detail Information

Publications12

  1. ncbi Vitamin D and non-Hodgkin lymphoma risk in adults: a review
    Jennifer L Kelly
    Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14642, USA
    Cancer Invest 27:942-51. 2009
    ..This review provides a comprehensive discussion of the current epidemiologic evidence with regard to the investigation of an association between vitamin D status and NHL risk...
  2. ncbi A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults
    Jennifer L Kelly
    Department of Community and Preventive Medicine, University of Rochester, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA
    Cancer Causes Control 21:1265-75. 2010
    ....
  3. ncbi High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
    Makiko Ban-Hoefen
    James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    Leuk Lymphoma 53:830-5. 2012
    ..However, patients exposed to rituximab pre-transformation appear to have inferior HD-ASCT outcomes, and thus may benefit from novel conditioning and maintenance regimens in the setting of HD-ASCT...
  4. ncbi The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
    Jennifer L Kelly
    School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA
    Ann Epidemiol 22:855-62. 2012
    ..To evaluate the association of body mass index (BMI) and physical activity (PA) during adulthood and at the age of 18 years with risk of non-Hodgkin lymphoma (NHL)...
  5. ncbi Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
    Jennifer L Kelly
    School of Medicine and Dentistry, University of Rochester, NY, USA
    Cancer Causes Control 23:1017-29. 2012
    ....
  6. ncbi Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
    Jonathan W Friedberg
    James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    Br J Haematol 146:282-91. 2009
    ..This study is the first to histologically confirm perturbation of the local immune microenvironment following systemic biological therapy of follicular lymphoma...
  7. ncbi Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
    Matthew T Drake
    College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 28:4191-8. 2010
    ..Recent data also suggest that vitamin D insufficiency is related to inferior prognosis in some cancers, although there are no data for NHL...
  8. ncbi Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era
    Sarah F Keller
    James P Wilmot Cancer Center, University of Rochester, Rochester, New York 14642, USA
    Biol Blood Marrow Transplant 18:640-7. 2012
    ..Our results emphasize the importance of long-term follow-up for both toxicity and recurrence, and have important implications in defining success of posttransplantation maintenance strategies...
  9. ncbi Testicular cancer survivorship: research strategies and recommendations
    Lois B Travis
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA
    J Natl Cancer Inst 102:1114-30. 2010
    ..Just as testicular cancer once served as the paradigm of a curable malignancy, comprehensive follow-up studies of testicular cancer survivors can pioneer new methodologies in survivorship research for all adult-onset cancer...
  10. ncbi The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma
    Jonathan W Friedberg
    James P Wilmot Cancer Center, University of Rochester, Rochester, NYm, USA
    Blood 117:2807-12. 2011
    ..On the basis of these promising results, the US cooperative groups have initiated randomized trials to evaluate this regimen in follicular and mantle cell lymphoma. This trial was registered at www.clinicaltrials.gov as #NCT00547534...
  11. ncbi Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
    Paul M Barr
    James P Wilmot Cancer Center, University of Rochester, Rochester, NY 14642, USA
    Clin Immunol 142:237-42. 2012
    ....
  12. ncbi Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens
    Jennifer L Kelly
    James P Wilmot Cancer Center, University of Rochester, Rochester, NY 14642, USA
    Clin Lymphoma Myeloma 9:307-10. 2009
    ....